Matthew Dubofsky


I am dedicated to helping high-growth companies achieve their strategic goals.

Matthew P. Dubofsky focuses on capital markets transactions, representation of public companies and M&A. He regularly represents issuers and underwriters in capital markets transactions and sell-side and buy-side clients in M&A transactions. Matt also represents emerging companies and has deep experience across a variety of industries, including information technology, cybersecurity, software, retail, biotechnology and medical devices.

Download full bio 


  • DispatchHealth Expands Business With Two Strategic Acquisitions 

  • Guild Closes $175 Million Series F Financing Round 

  • Guild Education Valuation Climbs to $3.75 Billion With Series E Round 

  • UiPath – $1.5 Billion IPO 

  • Origin to List on Nasdaq via SPAC Merger With Artius 

  • View all


  • Harvard Law School
    JD, cum laude, 2004

  • Brown University
    BA, Economics and History

Admissions & Credentials



  • American Bar Association

  • Colorado Bar Association

KemPharm in its initial public offering and public company matters

Datalogix in its sale to Oracle

Rally Software in its initial public offering, follow-on offering, public company matters and sale to CA

GlobeImmune in its initial public offering

Jazz Pharmaceuticals in convertible debt and equity offerings